Cefiderocol and Moxifloxacin Have Additive and Synergistic Activity Against Pseudomonas aeruginosa Including an

Eric G Romanowski1, Brennan M Schilling2, Emily K Young1

  • 1Charles T. Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.

Abstract

Insights

Cefiderocol and moxifloxacin show synergy against drug-resistant Pseudomonas aeruginosa keratitis. This combination offers a promising new treatment for challenging ocular infections caused by resistant bacteria.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • The 2023 Pseudomonas aeruginosa keratitis outbreak highlighted the urgent need for novel treatments against multi-drug-resistant (MDR) and extensively drug-resistant (XDR) bacteria.
  • Increased prevalence of lasR mutant keratitis isolates necessitates understanding quorum-sensing defects' impact on antibiotic efficacy.

Purpose of the Study:

  • To evaluate the in vitro efficacy and synergistic potential of cefiderocol and moxifloxacin against P. aeruginosa keratitis isolates.
  • To assess the influence of quorum-sensing defects on the efficacy of this antibiotic combination.
  • To compare cefiderocol-moxifloxacin synergy with ceftazidime-moxifloxacin, using ceftazidime as a comparator lacking cefiderocol's iron-binding entry mechanism.

Main Methods:

  • Time-kill assays and epsilometer (E-test) were employed to determine minimum inhibitory concentrations (MICs) and drug interactions.
  • Fractional inhibitory concentration indices (FICI) were calculated to classify interactions as antagonistic, indifferent, additive, or synergistic.
  • Quorum-sensing defective strains were identified via a characteristic colony sheen phenotype linked to LasR system defects.

Main Results:

  • Consistent synergistic interactions between cefiderocol and moxifloxacin were observed in time-kill studies against all seven tested P. aeruginosa keratitis isolates, including one from the 2023 outbreak.
  • E-test assays revealed additive or synergistic activity in 79% of isolates, decreasing to 60% in suspected quorum-sensing defective strains.
  • The ceftazidime-moxifloxacin combination demonstrated reduced efficacy, especially against sheen-positive strains. Cefiderocol-moxifloxacin showed indifferent effects against Serratia marcescens and Staphylococcus aureus.

Conclusions:

  • Cefiderocol and moxifloxacin exhibit significant in vitro synergy against the majority of tested P. aeruginosa keratitis isolates, even those with quorum-sensing defects.
  • This combination warrants further investigation as a potential therapeutic strategy for managing highly drug-resistant ocular infections.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
889
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.3K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
486